catalyst

A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Sc — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2023-03-12 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Sc — primary completion
Type
Trial Readout
Date
2023-03-12
Date type
ACTUAL
Phase
Phase 2
This event happened.
relationships
The graph out of here
trial
A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms
trial